Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 110 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Hydroxymethylglutaryl-CoA Reductase Inhibitors  [Clear All Filters]
2012
Lazich, I., Sarafidis P., de Guzman E., Patel A., Oliva R., & Bakris G. (2012).  Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.. Diabetes Obes Metab. 14(2), 181-6.
Kirmizis, D., Papagianni A., Dogrammatzi F., Belechri A-M., Alexopoulos E., Efstratiadis G., et al. (2012).  The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.. Ren Fail. 34(9), 1135-9.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.. J Clin Lipidol. 6(1), 93.
Athyros, V. G., Elisaf M. S., Alexandrides T., Achimastos A., Ganotakis E., Bilianou E., et al. (2012).  Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.. Angiology. 63(5), 358-66.
Athyros, V. G., & Mikhailidis D. P. (2012).  Pharmacotherapy: statins and new-onset diabetes mellitus--a matter for debate.. Nat Rev Endocrinol. 8(3), 133-4.
Lalountas, M., Ballas K. D., Michalakis A., Psarras K., Asteriou C., Giakoustidis D. E., et al. (2012).  Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model.. Br J Surg. 99(3), 423-9.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2012).  Stage of chronic kidney disease and severity of coronary heart disease manifestation.. Expert Opin Pharmacother. 13(4), 457-60.
Koskinas, K. C., & Giannoglou G. D. (2012).  Statins, plaque regression, and arterial remodeling: systemic drug effect, local effect, or a combination thereof?. Am J Cardiol. 110(2), 318.
Kostapanos, M. S., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Therapeutic options for statin-intolerant patients.. Curr Med Res Opin. 28(3), 345-9.
2011
Athyros, V. G., Karagiannis A., Ganotakis E. S., Paletas K., Nicolaou V., Bacharoudis G., et al. (2011).  Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study.. Curr Med Res Opin. 27(8), 1659-68.
Anagnostis, P., Selalmatzidou D., Polyzos S. A., Panagiotou A., Slavakis A., Panagiotidou A., et al. (2011).  Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study.. Int J Clin Pract. 65(6), 679-83.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.. Int Angiol. 30(3), 295; author reply 296.
Anagnostis, P., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Impact of statins on glucose metabolism--a matter of debate.. Am J Cardiol. 107(12), 1866.
Makras, P., Anastasilakis A. D., Polyzos S. A., Bisbinas I., Sakellariou G. T., & Papapoulos S. E. (2011).  No effect of rosuvastatin in the zoledronate-induced acute-phase response.. Calcif Tissue Int. 88(5), 402-8.
Pagourelias, E. D., Gossios T. D., Tziomalos K., Karagiannis A., Geleris P., & Athyros V. G. (2011).  Residual cardiac risk reduction beyond lipid lowering.. Hellenic J Cardiol. 52(3), 197-203.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Vitamin D deficiency, statin-related myopathy and other links with vascular risk.. Curr Med Res Opin. 27(9), 1691-2.
2010
Kadoglou, N. P. E., Sailer N., Moumtzouoglou A., Kapelouzou A., Gerasimidis T., & Liapis C. D. (2010).  Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.. J Vasc Surg. 51(1), 114-21.
Athyros, V. G., Tziomalos K., Karagiannis A., Wierzbicki A. S., & Mikhailidis D. P. (2010).  Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?. Curr Opin Cardiol. 25(4), 406-10.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Atorvastatin: safety and tolerability.. Expert Opin Drug Saf. 9(4), 667-74.
Kadoglou, N. P. E., Gerasimidis T., Kapelouzou A., Moumtzouoglou A., Avgerinos E. D., Kakisis J. D., et al. (2010).  Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.. Eur J Vasc Endovasc Surg. 39(3), 258-65.
Saratzis, A., Kitas G. D., Saratzis N., & Melas N. (2010).  Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.. Angiology. 61(2), 137-44.
Katsiki, N., Tziomalos K., Chatzizisis Y., Elisaf M., & Hatzitolios A. I. (2010).  Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental?. Atherosclerosis. 211(1), 9-14.
Kostakou, P., Kolovou G., Anagnostopoulou K., Theodoridis T., Galea V., Mihas C., et al. (2010).  Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia.. Arch Cardiovasc Dis. 103(1), 26-32.
Athyros, V. G., Mitsiou E. K., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy.. Expert Opin Pharmacother. 11(5), 723-30.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.